Anlon Healthcare Subscription Day 3

Fri Aug 29 2025

Here, Anlon Healthcare launched on 26th August 2025. The issue will be closed for bidding today, on 29th August 2025. The primary aim of Anlon Healthcare is to raise ₹121.03 crores from the market. Additionally, Anlon Healthcare has received an impressive level of subscription, which suggests that the shares will be listed at a remarkable premium. Scroll down to check the Anlon Healthcare subscription and details.

Table of Contents

Anlon Healthcare Details

IPO Open Date	26th August 2025
Face Value	₹10 per share
Price Band	₹86 to 91 per share
Lot Size	164 Shares
Issue Type	Bookbuilding IPO
Listing At	BSE and NSE
IPO Close Date	29th August 2025
Listing Date	3rd September 2025

The price band for Anlon Healthcare has been prescribed as ₹86 to ₹91 per share, with a total of 1,33,00,000 shares issued. Let’s segregate the share quota fixed for different categories of investors.

Categories	Shares Offered	% Shares offered
QIB Shares Offered	99,75,000	0.00%
NII (HNI) Shares Offered	19,95,000	15.00%
Retail Investors	13,30,000	10.00%
Total Shares Offered	1,33,00,000	100.00%

Anlon Healthcare Subscription Status

As of now, Anlon Healthcare has been subscribed to 6.42 times. Of these, 42.91 times are subscribed by retail investors, 8.87 times by non-institutional investors, and 1.06 times by QII (Qualified Institutional Investors).

The healthy subscription status indicates that investors are expecting higher returns at the time of the Anlon Healthcare listing on 3rd September 2025. Anlon Healthcare also has a positive outlook behind the fresh issue of 1.33 crore shares, which is expected to raise around Rs 121.03 crore.

Anlon Healthcare GMP Today

We know that higher subscription prices encourage grey market premiums for IPOs. Let’s explore the Anlon Healthcare GMP for 29th August 2025.

The grey market premium for this IPO is 5.49% or Rs 2 per share. It indicates that the estimated listing price per share is Rs 93. Numerous factors played a pivotal role in this jump in Anlon Healthcare’s IPO GMP. These include higher subscription rates received, positive market sentiments, and investors’ positive attitude towards IPOs.

About Anlon Healthcare Ltd.

Anlon Healthcare Limited is a chemical manufacturing company specialising in the production of high-purity, advanced pharmaceutical intermediates, which serve as raw materials or key starting materials in the manufacture of active pharmaceutical ingredients. The company also undertakes API development, preparation, and filing of Drug Master Files (DMFs) in the Indian and global markets, as per the pharmacopoeia requirements of customers and regulatory agencies. In addition to manufacturing pharma intermediates and APIs in accordance with various domestic and international standards, we have recently begun offering custom manufacturing services for complex or novel chemical compounds. We tailor the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards.

Financial Performance

Assess the company’s financial performance over the past three years to gauge expectations for the Anlon Healthcare listing.

Year Ended	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023 (in cr.)
Assets	181.30	128.00	111.55
Revenue	120.46	66.69	113.12
Profit After Tax	20.52	9.66	5.82
EBITDA	32.38	15.57	12.66
Net Worth	80.42	21.03	7.37
Reserve and surplus	40.57	5.03	-4.63
Total Borrowing	58.35	74.56	66.39

Explanation

Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of Anlon Healthcare.

Key Indicators	Value
PE Ratio (Price-to-Earnings)	17.67
EPS (Earnings Per Share)	5.15
RoNW	25.51
ROCE	21.93
ROE	40.45
EBITDA Margin	26.88
Price to Book Value	4.51
Market Capitalisation	₹483.68 Cr

Anlon Healthcare Listing Expectations

Anlon Healthcare: IPO allotment is still pending. However, according to current GMP or market sentiments, it is reasonable to expect higher listing gains from the share. A 2.20% jump in Anlon Healthcare GMP suggests that the estimated listing price per share will be approximately Rs 93.

It will provide higher listing gains to investors who applied for this IPO. Additionally, the financial fundamentals of this business made it the experts’ top long-term recommendations.

Anlon Healthcare Dates

IPO Open Date	26th August 2025
IPO Close Date	29th August 2025
Allotment	1st September 2025
Refund Date	2nd September 2025
IPO Listing Date	3rd September 2025

Note: IPO GMP is highly volatile, influenced by market sentiment. Hence, one should conduct their research before investing in it.